SMR · NuScale Power Corporation

Current Thesis

The only live narrative leg is a binary on undated sovereign capital: South Korea's reported $200B US-investment package said to be eyeing NuScale's Tennessee/TVA SMR program plus a first plant near Uljin, with Doosan Enerbility (a partner since 2019) and Samsung C&T cited in the talks (KED Global 2026-05-13, Motley Fool 2026-05-31). That headline drove a violent failure: +9.62% to ~$14.13 (6/2), then −13.08% to $12.13 (6/3), a continued bleed under $10, and a $9.89 close (6/12) that pressed the $8.85 52-week low before a +3.34% bounce on news of a new Virginia training center. A training center is not a contract. Fundamentals remain broken Q1 2026 revenue $0.565M (−96% YoY), net loss $44.02M and Citi Sell $7 / Goldman Neutral $9 both sit at or below spot. The headline-pop-then-fade signature has held since April. The setup is a pass on fresh entries; the watch is for a named capital figure or binding offtake arriving alongside a genuine higher-low base.

Bull Case

• South Korea / $200B package reportedly eyeing NuScale's Tennessee/TVA program and a first plant near Uljin; Doosan Enerbility + Samsung C&T cited as manufacturing/EPC partners (KED Global 2026-05-13, Motley Fool 2026-05-31). Sovereign-aligned capital is the highest-impact catalyst the name has carried since the RoPower FID.
• NRC standard-design approval uprated to 77 MWe (May 2025) the only approved multi-module US SMR design (second design cleared overall), a deployable-this-decade credential peers OKLO/NNE lack.
• Supply-chain build-out: Framatome fuel contract expanded 2026-03-10 (Business Wire / World Nuclear News) with direction to fabricate ≥444 fuel assemblies for the first US customer as early as 2030, now covering US + Europe; Ebara Elliott Energy R&D pact 2026-03-19 targets high-temperature steam compressors for petrochemical process heat (completion ~2027), widening the addressable market beyond grid power.
• DOE support: the US Energy Secretary told Congress the first 5–10 new reactors will "almost certainly" receive DOE loans, with NuScale named; the applicant window runs through July 2026.
• ENTRA1 + TVA framework for a potential ~6 GW US deployment; RoPower Romania 6-module project FID cleared 2026-02-12/13, with a go/no-go decision expected mid-2026 the first potential true commercial plant.
• Liquidity: ~$346M cash and ~$890M including short-term investments (~$1B total) as of Q1 2026 multi-year runway, no imminent forced raise.
• PT anchors above spot: Canaccord Buy $25 (June), Northland $19, B. Riley Buy $19 (Pfingst, 2026-04-24); consensus ~$15.36 (5 Buy / 9 Hold / 2 Sell of 17). Van Eck and Renaissance Technologies added to positions in Q1 2026.

Bear Case

• The tape is breaking, not basing: the $14.13 high (6/2) round-tripped to $12.13 (6/3) and bled to a $9.89 close (6/12), a ~−30% failure inside seven sessions that pressed the $8.85 52-week low. Every headline pop has faded since April.
• Q1 2026 (2026-05-07): revenue $0.565M vs ~$14.67M est (−96% miss), net loss $44.02M, EPS −$0.14 vs −$0.13 est. Revenue running backward at a pre-commercial name.
• Street cutting into the pop: Citi Sell $7 (operative bear target ~29% below spot), Goldman Neutral $9 (cut from $10, 2026-06-03) both at or under the $9.89 close.
• Zero signed commercial SMR contracts: the Korean talks remain unsigned and undated, and Motley Fool (2026-06-04) explicitly flags that Korean interest in US nuclear is not the same as a direct NuScale investment. The first firm order continues to slip toward late 2026.
• Insider distribution: 14 executive sales and zero purchases over the trailing six months (Quiver); founding sponsor Fluor exited its remaining stake in 2026.
• Base-rate risk: the prior first project (UAMPS/CFPP) ballooned toward ~$9B and $89→$119/MWh before its Nov 2023 cancellation the precedent for any RoPower capex-inflation disclosure.
• Structurally broken: ~−83% off the $57.42 high, bottom of the $8.85–$57.42 range, ~$3.6B market cap, below all major moving averages, with no higher-low base and no commercial power revenue expected before the early 2030s.

Setup & Price Structure

• Close $9.89 (6/12), +3.34% on the Virginia training-center headline; after-hours ~$10.01. 52-week range $8.85–$57.42; market cap ~$3.61B; average volume ~31.2M.
• The $14.13 high (6/2) → $9.89 collapse leaves the round $10 level and the broken-down $12 shelf overhead as resistance; the 6/12 bounce off ~$9 reads as distribution relief, not a confirmed turn.
• The $8.85 52-week low is the line in the sand. A higher low above it that reclaims the 20-EMA (~$11–12) on expanding volume is the first structural-repair signal; nothing on the current chart confirms that.
• The 6/5 leg lower printed ~45M shares (~45% above the 31.2M average) heavy supply into the decline, not accumulation.

Catalyst Calendar (next 30 days)

• ~Through July 2026 (est.): DOE advanced-reactor loan applicant window; NuScale cited among likely recipients, but no SMR-specific dated award.
• ~Mid-2026 (est.): RoPower Romania 6-module go/no-go decision the first potential commercial plant and a genuine binary.
• "July nuclear catalyst" chatter (Quiver, 2026-06-01): DOE's stated goal of operational SMRs by July 2026 is a sector-aspirational target; NuScale will not have an operating reactor by then.
• Undated: South Korea $200B package named allocation watch KED Global / Reuters for an actual dollar figure tied to NuScale.
• Q2 2026 earnings ~early Aug 2026 (est.; Q1 printed 2026-05-07) avoid fresh entries within 3 trading days of the print.

What Would Change Our Mind

• A named South Korea capital figure, or a binding offtake (≥$100/MWh for ≥250 MWe), attached to NuScale specifically rather than to "US nuclear" broadly.
• A RoPower "go" FID confirming a funded first commercial plant.
• A higher-low base reclaiming the 20-EMA (~$11.50) on expanding volume repair built over weeks, not a one-day headline spike.
• The bearish counter-condition: a weekly close below the $8.85 52-week low confirms the breakdown and removes any long case until a fresh base forms.

Correlation Notes

• The nuclear-uranium theme is MATURING, not accelerating; basket leadership rotated to OKLO/NNE earlier in the spring, and SMR trades as the laggard unless its relative-strength line versus OKLO turns up.
• One seat maximum in the nuclear basket avoid stacking SMR with OKLO/NNE/LEU/BWXT/CCJ on the same sovereign-capital or DOE-loan headline.
• High beta to speculative growth: the 6/5 leg lower coincided with a broad spec-tech selloff, layering factor risk on top of single-name binary risk.
• The SMR-specific drivers (Korean capital, RoPower, DOE loans) are increasingly idiosyncratic versus the AI-datacenter-power frame that powered the group in 2025, so a sector bid no longer reliably lifts this name.